Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011570 (
depression
)
172,036
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The authors report the clinical histories of two adults with profound mental retardation, features of rapid cycling bipolar disorder, and periodic maladaptive behaviour. In each case, primary features of mania and
depression
were identified, operationally defined and measured with an ongoing data system, which was used to track SIB and
aggression
. In the first case, data analysis across days showed that 1-week episodes of depressive features alternated with 2-week episodes of manic features and that SIB was only associated with the depressive features. In the second case, episodes of manic and depressive features alternated every few days, and
aggression
was only associated with the manic features. These cases suggest that severe behaviour problems can be a state-dependent phenomenon of bipolar disorder. The behaviour monitoring system provided an objective methodology for aiding in the diagnosis of bipolar disorder with profoundly handicapped adults.
...
PMID:Severe behaviour problems associated with rapid cycling bipolar disorder in two adults with profound mental retardation. 162 16
Thirty-three years ago, Gaddum and Picarelli classified the serotonin receptors in the guinea pig ileum into D and M types based on the activity of dibenzyline and morphine to block contractions of intestinal smooth muscle caused by serotonin. The subsequent location of specific ligand binding sites for serotonin in the brain has led to the identification of at least eight serotonin receptor sub-types in rat brain. While there is some controversy over the functional importance of many of these receptor sub-types, there is evidence that they fall into two major groups according to the nature of their coupling to secondary messengers or ion channels. Thus the 5-HT1 and 5-HT2 receptors appear to occupy the G protein receptor sub-family which may be coupled either to adenylate cyclase (most 5-HT1 sub-types) or phosphatidyl inositol (5-HT2 sub-types). The central "M" receptors (now termed 5-HT3) appear to occupy a ligand gated ion channel super-family. The cloning of three of the serotonin receptor sub-types in 1989 (5-HT1A, 5-HT1C and 5-HT2) has been of importance in enabling the receptor sub-types to be classified as specific protein molecules encoded by specific genes. The problem now arises with regard to the linking of the changes in the cellular activity of the various receptor sub-types with the plethora of behavioural changes that arise as a consequence of the actions of serotonin in the brain. The present review summarizes the evidence implicating the role of specific serotonin receptor sub-types in eating disorders, sleep, sexual activity, anxiety states,
aggression
, schizophrenia and
depression
. A summary of the relationship between these receptor sub-types and their possible involvement in the aetiology of these diseases is shown in Table 2.
...
PMID:Sub-types of serotonin receptors: biochemical changes and pharmacological consequences. 162 53
Various problems in relation to psychoanalytic theories of
aggression
are considered in a review which is by no means exhaustive but includes areas which have puzzled and interested the author. First to be considered is why the concept of
aggression
as a major drive was a relative late-comer in psychoanalysis; next the contentious concept of a 'death instinct' and some of the factors in Freud's lifetime which may have contributed to both. Then it is suggested that we seem to have theories of
aggression
which might be called primary or secondary in two different senses. First is the question whether
aggression
is innate or secondary to frustration. In another sense, primary and secondary theories of
aggression
seem to survive paralleling Freud's original primary and secondary theories of anxiety. In this sense the primary theory survives as an explanation of psychosomatic disorder. Lastly, the link between suicide and murder is considered and the turning of
aggression
against the self in
depression
and self-destructive attacks.
...
PMID:Psychoanalytic views of aggression: some theoretical problems. 163 26
Short-term outcomes were evaluated for 65 children who were followed for 2, 4, or 6 months after psychiatric hospitalization. Child (e.g.,
aggression
), parent (e.g.,
depression
), family dysfunction (caretaker inconsistencies), and the modalities of treatment (e.g., point system) are described. Analyses of variance revealed no effects of follow-up interval or length of stay. A regression analysis revealed that low improvement was predicted by child attention deficit disorder with hyperactivity and depressive symptoms, older age, neurological dysfunction, and history of physical abuse. High improvement compared with low improvement children had a more successful adjustment in several critical roles and exhibited fewer individual problem behaviors.
...
PMID:Short-term follow-up of child psychiatric hospitalization: clinical description, predictors, and correlates. 164 36
1. PE is present in the brain in tiny quantities; it is heterogeneously distributed and present in synaptosomes. 2. It is synthesised from phenylalanine by L-AADC and oxidatively deaminated by MAO-B. Its turnover is remarkably fast. 3. Its concentration, particularly in the caudate nucleus, is affected by MAO inhibition (increased), lesion of the Substantia nigra (decreased), amine depletion (increased) and antipsychotic drugs (increased). 4. When iontophoresed (or injected) it amplifies the effects of DA and NA (and their agonists) but is without effect on other neurotransmitters. 5. It is suggested that it acts postsynaptically as a neuromodulator of catecholaminergic neurotransmission and that it is involved in the mechanism of action of Deprenyl; it is also suggested that it, or its principal metabolite PAA, may be involved in the aetiology of schizophrenia,
depression
and
aggression
as well as perhaps in other neuropsychiatric conditions.
...
PMID:Phenylethylaminergic modulation of catecholaminergic neurotransmission. 165 28
Self-
aggression
is a behavioural disorder in which an individual damages its own body parts by intense biting or scratching. Self
aggression
has been reported in human patients in Lesch-Nyhan syndrome and in cases of schizophrenia,
depression
, and congenital analgesia. In human patients as well as in experimental animals some kind of dysesthesia of the part of the body that is mutilated has been suggested. This study was conducted to find out the underlying pain mechanisms in self-aggressive behaviour arising out of stereotypy. The study was performed in 40 adult male rats. In all these animals, self-
aggression
was produced as part of amphetamine induced stereotyped behaviour. A predetermined scale was used for quantifying this behaviour. Reserpine and phenoxybenzamine pretreatment led to an increase in the incidence of self-
aggression
. Naloxone administration in reserpine pretreated animals led to a further significant increase in the incidence of self biting as compared to controls. From these studies it appears that self-aggressive behaviour may be associated with increased pain sensation.
...
PMID:Role of opioid receptors in self-aggression in rats. 166 47
Several developments in serotonin neuropharmacology have implications for psychiatric disorders and have already begun to impact their treatment. Selective inhibitors of serotonin uptake, which enhance serotonergic function by preventing the removal of serotonin from the synaptic cleft via the membrane transporter, have been introduced for the treatment of
depression
and may be effective in other disorders. Precursor loading can increase serotonin concentrations in the synaptic cleft, and tryptophan--which has been available in health food stores and drug stores--had become increasingly used for self-medication of
depression
, insomnia, and premenstrual syndrome. Conversion to serotonin is not the major metabolic pathway for tryptophan, and large increases in other tryptophan metabolites (such as quinolinic acid, a substance that is excitotoxic at high concentrations) accompany small increases in extracellular serotonin. The recent epidemic of the eosinophilia-myalgia syndrome associated with tryptophan now appears due to a trace contaminant in the product from a single manufacturer. A major advance in serotonin pharmacology has been the elucidation of serotonin receptor heterogeneity. At least seven receptor subtypes (5-HT1A, 5-HT1B, 5-HT1C, 5-HT1D, 5-HT2, 5-HT3, 5-HT4) have been identified in brain. Direct-acting agonists and antagonists can have selective affinity for specific receptor subtypes. Selective activation of 5-HT1A receptors seems to cause anxiolytic and possibly antidepressive effects. Selective antagonists of 5-HT2 or 5-HT3 receptors may be useful in treating anxiety and schizophrenia. Drugs that enhance serotonergic function suppress
aggression
in animals, but the specific receptor subtypes involved are not known. The advances being made in serotonin pharmacology will help define the role of this brain neurotransmitter in psychiatric and other disorders and can be expected to lead to further therapeutic advances.
...
PMID:Role of serotonin in therapy of depression and related disorders. 167 51
Although the psychological profile of patients requesting cosmetic surgery is often similar, the consequences of surgery can be dramatic in certain cases and result in a true state of rupture. The various forms,
depression
or
aggression
, and the conditions of onset are analysed. The four essential predisposing factors are: lack of information, result-satisfaction dichotomy, patient-surgeon divorce, and the responsibility of colleagues who, as a result of their inconsiderable comments, destabilize an already fragile psychological state.
...
PMID:[Esthetic surgery and psychological rupture states]. 172 85
Describes a conceptual framework for identifying and targeting developmental antecedents in early childhood that have been shown in previous work to predict delinquency and violent behavior, heavy drug use,
depression
, and other psychiatric symptoms and possibly disorders in late adolescence and into adulthood. Criteria are described that guided choices of targets for two epidemiologically based, randomized preventive trials carried out in 19 elementary schools in the eastern half of Baltimore, involving more than 2,400 first-grade children over the course of first and second grades. Baseline models derived from the first of two cohorts show the evolving patterns of concurrence among the target antecedents. The central role of concentration problems emerged. From Fall to Spring in first grade, concentration problems led to shy and
aggressive behavior
and poor achievement in both genders and to depressive symptoms among girls. There was evidence for reciprocal relationships in girls. For example, depressive symptoms led to poor achievement in both girls and boys, whereas poor achievement led to depressive symptoms in girls but not boys, at least over the first-grade year. These results provide important epidemiological data relevant to the developmental paths leading to the problem outcomes and suggest preventive trials.
...
PMID:Developmental epidemiologically based preventive trials: baseline modeling of early target behaviors and depressive symptoms. 175 36
Streptozocin-induced diabetic (STZ-D) mice have reduced brain concentrations of tryptophan, a precursor substance for 5-hydroxytryptamine, and show lengthened immobility in Porsolt's swim test, a putative animal model of
depression
. This study investigated whether tryptophan affects behavior in Porsolt's swim test in STZ-administered male National Institutes of Health Swiss mice. In addition, the effect of tryptophan on behavior in the resident-intruder test of
aggression
was studied. Tryptophan is effective in the treatment of mild
depression
and may reduce
aggressive behavior
. Diabetes was induced with injection of 200 mg/kg body wt i.p. STZ. Two weeks after STZ treatment, the mice received 0, 50, and 100 mg/kg i.p. tryptophan 60 min before the swim test. The STZ-administered mice exhibited lengthened immobility in the swim test, and tryptophan caused a dose-related shortening in their immobility times. The control and STZ mice, which were isolated for 1 wk before the resident-intruder test, did not show any difference in the time spent in social investigation or aggressive or defensive behaviors. However, 100 mg/kg i.p. tryptophan 60 min before the test reduced the social interaction and
aggressive behavior
of the STZ-D mice but increased these behaviors in controls. Results indicate that tryptophan shortens the increased immobility time and reduces social and
aggressive behavior
in STZ-D mice. Therefore, the reported reductions in the brain-tryptophan concentrations in STZ-D mice may participate in regulating their behavior.
...
PMID:Effects of tryptophan on depression and aggression in STZ-D mice. 175
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>